QIAGEN CLC Genomics

Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection

221 views
October 25, 2023
Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw.

In this seminar, you’ll learn:

From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.

Related videos

QIAGEN CLC Genomics

Workflow construction and customization using QIAGEN CLC Genomics Workbench

85 views February 29, 2024

Recently we have received some requests from CLC users (as well as CLC...

QIAGEN CLC Genomics

Long reads analysis using QIAGEN CLC Genomics workbench (with new features - 2024)

127 views February 20, 2024

This webinar will introduce users to the long read support plugin for Oxford...

QIAGEN CLC Genomics

What’s new in QIAGEN CLC Genomics Workbench version 24

182 views January 31, 2024

QIAGEN CLC Genomics Workbench version 24 is here with exciting updates we'd...

QIAGEN CLC Genomics

Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

352 views August 21, 2023

This two-part series will walk you through single-cell RNA sequencing...